DNTH - Dianthus Therapeutics, Inc. /De/ - SEC Form 4 Insider Trading Screener

Manufactured Goods - Chemicals - Pharmaceutical Preparations - DNTH (1690585)
General
Tickers
Insider
Sh Price $
Lqdty M$
Date
Filing Date
  
Trade Date
  
Filing Delay
N Days Ago
Transaction Filing
 P - Purchase
 S - Sale
 A - Grant
 D - Sale to Iss
 G - Gift
 F - Tax
 M - Option Ex
 X - Option Ex
 C - Cnv Deriv
 W - Inherited
No deriv Multiple Days
Traded K$
Own Chg %
Industry
Insider Title     Officer
    COB
    CEO
    Pres
    COO
    CFO
    GC
    VP
  Director
  10%own
  Other
Group by
Sort by
Max Results
Page
   clear
6 results. Finviz
TCcnt1d1w1m6m

X

Filing Date

Trade Date

Ticker

Insider Name

Title

Trade Type  

Price

Qty

Owned

ΔOwn

Value

1d

1w

1m

6m

2023-09-29
DNTHFairmount Funds Management LLCDir, 10%P - Purchase$13.63+24,6701,928,503+1%+$336,252
2023-09-26
DNTHFairmount Funds Management LLCDir, 10%P - Purchase$13.15+30,0001,903,833+2%+$394,500
M
2023-09-21
DNTHRandhawa SimratChief Medical OfficerP - Purchase$13.20+4,0004,000New+$52,800
2023-09-19
DNTHFairmount Funds Management LLCDir, 10%P - Purchase$13.20+30,0001,873,833+2%+$396,000
DM
2023-09-12
DNTHFairmount Funds Management LLCDir, 10%P - Purchase$11.20+24,2541,843,833+1%+$271,680
M
2023-02-07
MGTAThird Rock Ventures Iv, L.P.10%S - Sale$0.83-3,700,0003,058,204-55%-$3,056,000

AAmended filing
DDerivative transaction in filing (usually option exercise)
EError detected in filing
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top